TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2014

A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.

Alex F Herrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.